CFAR Seminar: Prospects for achieving a functional cure from AIDS through therapeutic vaccination

Event Date & Time: 
November 1, 2012 - 4:00pm to 5:00pm

Deborah Fuller, PhD

University of Washington

Location: Pelton Auditorium, Fred Hutchinson Cancer Research Center

Deborah Fuller, Ph.D. is an Associate Professor in the Department of Microbiology at the University of Washington and Core Scientist at the Washington National Primate Research Center. She received her Ph.D. in Molecular and Cellular Pathology at the University of Wisconsin-Madison and has worked as a PI in academia since 2004. Prior to her academic appointments, Dr. Fuller was as a lead scientist in the biotechnology industry for 15 years (most recently PowderJect Vaccines, Inc.) where she played a key role in the earliest studies investigating the feasibility of DNA vaccines from animal models to human clinical trials and led a research team that distinguished the gene gun as the first DNA vaccine strategy to induce protective levels of immunity in a human clinical trial. Dr. Fuller’s current projects are to improve the potency of DNA vaccines, develop and test new vaccine technologies, investigate the role of mucosal immunity and CD8+ T cell responses in control of influenza and HIV, and investigate the feasibility of these concepts for immunotherapy and prophylaxis in the highly relevant SIV macaque model for AIDS. Dr. Fuller has authored over 60 scientific articles in vaccines and infectious diseases and is an inventor on 9 awarded patents in DNA vaccines.

View Webcast